Lornamead Revenue and Competitors

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Lornamead's estimated annual revenue is currently $29.3M per year.(i)
  • Lornamead's estimated revenue per employee is $201,000

Employee Data

  • Lornamead has 146 Employees.(i)
  • Lornamead grew their employee count by -8% last year.

Lornamead's People

NameTitleEmail/Phone
1
VP SalesReveal Email/Phone
2
VP Marketing, US Health and Personal CareReveal Email/Phone
3
VP, research, Development and EngineeringReveal Email/Phone
4
Controller & HR ManagerReveal Email/Phone
5
ControllerReveal Email/Phone
6
SVP, SalesReveal Email/Phone
7
Director Marketing, Oral CareReveal Email/Phone
8
Marketing Director, Skin CareReveal Email/Phone
9
directorReveal Email/Phone
10
Marketing ManagerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$12.3M617%N/AN/A
#2
$354.3M461-2%$567.1MN/A
#3
$377.1M1876-1%N/AN/A
#4
$7.8M398%N/AN/A
#5
$5.4M270%N/AN/A
#6
$45M2246%N/AN/A
#7
$6.8M34-82%N/AN/A
#8
$9.2M4612%N/AN/A
#9
N/A69446%N/AN/A
#10
$15.5M775%N/AN/A
Add Company

What Is Lornamead?

Lornamead is a leading privately held global marketer of personal care brands. Our business focuses on acquiring and investing in heritage brands in order to maximise their growth potential. Since our establishment in 1978, we have grown into an international company with five well established international platforms, with others developing as new markets grow. Our specialist teams across the world are dedicated to supporting and growing our brands so that we can continue to satisfy consumer needs for quality hair care products, efficacious cosmetics and skin care, indulgent yet sophisticated fragrances and bath luxuries as well as the latest innovation in home tooth whitening.

keywords:N/A

N/A

Total Funding

146

Number of Employees

$29.3M

Revenue (est)

-8%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$15M14611%N/A
#2
$44.7M146-3%$210.8M
#3
$22M1466%$58M
#4
$43.4M146-1%N/A
#5
$37.6M1468%N/A